Pump.fun, a memecoin launchpad built on the Solana platform, has found itself at the center of a controversy regarding the withdrawal of a large sum of USDC worth $436.5 million since October 15. Analysis by crypto researcher EmberCN showed that the group withdrew $405 million USDC to Kraken in the last week and also transferred […]Pump.fun, a memecoin launchpad built on the Solana platform, has found itself at the center of a controversy regarding the withdrawal of a large sum of USDC worth $436.5 million since October 15. Analysis by crypto researcher EmberCN showed that the group withdrew $405 million USDC to Kraken in the last week and also transferred […]

Pump.fun Faces Backlash After $436 Million Withdrawal, PUMP Token Plunges

2025/11/24 19:30
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]
  • Pump.fun withdraws $436.5 Million USDC since October, sparking community backlash over transparency and fund use.
  • PUMP token falls over 22% in a week, trading at $0.002626, below the June private sale price.
  • Large SOL sales totaling $757M from May 2024 to August 2025 raise further community concerns.

Pump.fun, a memecoin launchpad built on the Solana platform, has found itself at the center of a controversy regarding the withdrawal of a large sum of USDC worth $436.5 million since October 15.

Analysis by crypto researcher EmberCN showed that the group withdrew $405 million USDC to Kraken in the last week and also transferred $466 million USDC from Kraken to the USDC pool at Circle. This action reportedly signifies a large withdrawal of funds.

According to reports, this money came from the private sale of PUMP tokens by Pump.fun in June 2024. The project launched its PUMP token in July and raised $500 million in less than 12 minutes in the initial coin offering. In spite of this big fund movement, the X account of Pump.fun has been mute for over a week without explanations.

Pump.fun Sparks Community Backlash

Since mid-October, the network has transferred $436.5 million of USDC to Kraken, followed by $537.6 million transferred from Kraken to Circle, as per Arkham insights. The protocol has also sold 4.19 million SOL from May 2024 to August 2025, worth approximately $757 million.

According to Lookonchain data, approximately 264,373 SOL tokens were sold on chain at a value of about $41.64 million, and about 3.93 million SOL tokens (valued at about $715.5 million).

The community response has been rather negative. A user posted that Pump.fun has made over $1 billion in the last year without contributing to the community: “No airdrops, no marketing, no incentives” on X. Another community member reacted negatively to the founder Alon’s Q4 because it only benefits the Pump.fun community and not the users.

Also Read | Pmp.fun (PUMP) Price Analysis: Bullish Triangle Pattern Targets $0.0095

PUMP Token Sparks Community Concerns

The PUMP token has experienced reductions in value as the withdrawals continue. In the past week, the token has fallen in value by over 22% and is currently trading at $0.002626 against the $0.004 price at which the June private sale occurred.

Source: CoinMarketCap

Pump.fun has also launched the “Mayhem Mode” functionality, which makes use of AI technology in the context of token launches. However, according to The Block, there has been only a slight increase in the number of token launches per day from 17,300 to 17,800.

The community is also wary due to the poor communication of Pump.fun’s project, large withdrawals of funds, and losses of tokens. This not only reinforces the dangers of large-scale memecoins but also the risks of launch.

Also Read | Pump.fun Boosts Daily Buybacks to $990K While PUMP Faces Sharp Market Correction

Market Opportunity
pump.fun Logo
pump.fun Price(PUMP)
$0.001899
$0.001899$0.001899
-0.05%
USD
pump.fun (PUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09